risk-based monitoring

The risk-based monitoring tag follows discussions about how monitoring practices change when AI and enterprise cloud systems enter regulated clinical-trial operations. Current coverage centers on Icon’s Microsoft partnership, Copilot, and the Orbis agentic AI platform, with attention to how these tools may affect sponsors, clinical research sites, contracts, data infrastructure, and change management. It highlights a practical governance question: whether existing, documented monitoring approaches and controlled systems can accommodate AI-enabled acceleration without creating unplanned obligations or weakening oversight. Readers will find analysis of operating-model changes, accountability, and the need to align technology adoption with the requirements of active studies.